March 18, 2026

By Patty Sipes, Managing Director, Alder Brooks
Q1 is almost over.
And if you’ve been in this industry long enough, you know what’s coming.
M&A announcements are about to hit.
It happens every year.
And I’m seeing it again right now across private equity-backed healthcare and life sciences companies.
M&A activity is accelerating.
Deal volume is increasing. Confidence is returning.
But the failure point hasn’t changed.
👉 Post-merger integration—specifically culture integration—is still where deals break down.
Not strategy.
Not financial modeling.
People. Leadership. Culture.
You can acquire:
But if you don’t align:
You will lose momentum quickly.
Culture integration is not a soft issue.
It is a core driver of deal value.
Commercial teams are often the first to feel the impact post-acquisition.
The organizations that win:
👉 Align commercial strategy early
👉 Retain top performers
👉 Communicate clearly and consistently
You are not supporting the integration.
👉 You are driving it.
The highest-performing organizations:
A few realities:
Do:
Don’t:
Across private equity portfolio companies and executive search engagements, the pattern is clear:
The most successful M&A outcomes happen when:
M&A is heating up again across:
The opportunity is significant.
But so is the risk.
👉 The companies that win will treat culture integration with the same discipline as financial performance.